Did you know that your browser is out of date?
For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
Learn About Our Breadth of Experience in Vaccine Litigation
NERA’s economists have played key roles in vaccine litigation involving alleged patent infringement, trade secrets, valuation and pricing, securities matters, product liability, antitrust claims, and class actions.
NERA Transfer Pricing Practice Welcomes Top TP Strategist
Dr. Niraja Srinivasan joins NERA economists in shaping global transfer pricing policy and creating opportunities for clients, bringing more than two decades of experience in Fortune-50 tax divisions and transfer pricing consulting firms.
Meet the Author: Dr. Omar Robles Talks Patent Density
Take a deep dive into Dr. Robles' analysis of a decade of Orange Book data, learn about his methodology, and hear about interesting new areas of research.
Preliminary Evidence of Disproportionate Impacts of COVID-19 and MAE Disputes
In a new Law360 paper, Managing Director Dr. David Tabak and Consultant Edward Flores examine how preliminary evidence of disproportionate impacts of the pandemic may shape material adverse effect (MAE) disputes.
Resilience in the Face of Unprecedented Change
Much has changed in the world in recent weeks, but our commitment to you hasn’t. Here’s what our clients and colleagues need to know about NERA’s support for you during this pandemic.